Annual Drug Patent Expirations for DEXILANT
Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from three suppliers. There are seventeen patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for DEXILANT.
This drug has sixty-four patent family members in twenty-five countries.
The generic ingredient in DEXILANT is dexlansoprazole. Three suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
